LY 3884965
Alternative Names: LY-3884965; PR 009Latest Information Update: 19 Jul 2024
At a glance
- Originator Prevail Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference; TREM2 protein expression stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Leukoencephalopathies